Hero

ETHRIS GmbH

Main Industry
Research & Development
updated 
updated 

Key Facts

This company profile is a search result of implisense.com

E-Mail

Website

Phone

Products and Services

EntwicklungBiotechnologieSoftware

Size (Revenue & Employees)

Medium-sized company

Balance sheet total

20 M €

Purpose

Erforschung und Entwicklung von neuen Therapieverfahren und -produkten zur Behandlung erworbener und angeborener Erkrankungen sowie im Zusammenhang damit der Erwerb und die Vergabe von Lizenzen und Übernahme von Beratungs-, Handels- und Vertriebsaktivitäten.

More? Implisense Plus!

Order Implisense Plus now for full company profiles and complete functionality! You will then have access to our GDPR-compliant real-time contact search, full annual reports, all search filters, complete search results and integrated AI analyses of the business model and management report.

  • Real-time search for contact persons
  • Complete annual reports
  • More search filters and results
Order now

Customer Relationship Intelligence: The Key to Optimizing your Sales Processes

Use our AI-powered assistants to identify the right companies, track current developments and market changes, reach relevant decision-makers and perfect your sales strategy with data-based insights. All seamlessly integrated into your CRM.

  • Find the right companies
  • Keep an eye on your target companies
  • Reach the right decision-makers
  • Increase your closing rate

Executive Summary

Implisense Assist gives you the opportunity to use AI to find out about companies via chat, analyze them and much more. We from the Implisense team also provide you with ready-made analyses, e.g., an executive summary and a financial analysis. Just try it out for yourself!

Implisense Plus
implisense assist

profile random user logo

implisense assist

Contacts

  • Carsten Rudolph
  • Christian Plank
  • Christian Marco Wawrzinek

Timeline

Register Announcements

Eigenkapital und Anlagevermögen wachsen 2023 bei der ETHRIS GmbH

Die ETHRIS GmbH konnte im Berichtsjahr 2023 das Eigenkapital um % auf Euro und das Anlagevermögen um % auf Euro wesentlich vergrößern. Diese Veränderung weist auf eine Erhöhung der langfristigen Investitionen hin. Der gerade veröffentlichte Jahresabschlussbericht ist ab sofort einsehbar.

Beginn des Förderprojektes "KMUi-Biomedizin-4: Kurative mRNA-Therapie für primäre Ziliendyskinesie (cuRNA-PCD) - präklinischer Proof-of-Concept, CMC und Sponsorverantwortung in einer klinischen Studie " (BMBF 03LW0647K)

Heute startet das Förderprojekt "KMUi-Biomedizin-4: Kurative mRNA-Therapie für primäre Ziliendyskinesie (cuRNA-PCD) - präklinischer Proof-of-Concept, CMC und Sponsorverantwortung in einer klinischen Studie ". Es wird vom BMBF unter dem Förderkennzeichen 03LW0647K für die ETHRIS GmbH mit einer Summe von 3.574.218,00 Euro gefördert. Die Laufzeit des Projektes beträgt 36 Monate.

ETHRIS GmbH 2022: Deutliche Steigerung der Bilanzsumme!

Die Bilanzsumme der ETHRIS GmbH hat sich im Fiskaljahr 2022 um % verglichen mit dem Vorjahreswert auf Euro wesentlich erhöht. Diese Veränderung lässt möglicherweise auf eine Zunahme der Vermögensbasis schließen. Der neu veröffentlichte Jahresabschluss ist ab sofort einsehbar und präsentiert umfangreiche Auswertungen und Trends.

Beginn des Förderprojektes "CNATM: Chemisch modifizierte Nukleoside, Nukleotide und Oligonukleotide als Therapeutika und Vakzine (Verbundprojekt 1) - G" (BMBF 03ZU1201AG)

Heute startet das Förderprojekt "CNATM: Chemisch modifizierte Nukleoside, Nukleotide und Oligonukleotide als Therapeutika und Vakzine (Verbundprojekt 1) - G". Es wird vom BMBF unter dem Förderkennzeichen 03ZU1201AG für die ETHRIS GmbH mit einer Summe von 97.001,00 Euro gefördert. Die Laufzeit des Projektes beträgt 36 Monate.

Beginn des Förderprojektes "CNATM: Antisense-Oligonukleotide und andere Nukleinsäuretherapeutika (Verbundprojekt 2) - J" (BMBF 03ZU1201BJ)

Heute startet das Förderprojekt "CNATM: Antisense-Oligonukleotide und andere Nukleinsäuretherapeutika (Verbundprojekt 2) - J". Es wird vom BMBF unter dem Förderkennzeichen 03ZU1201BJ für die ETHRIS GmbH mit einer Summe von 277.781,00 Euro gefördert. Die Laufzeit des Projektes beträgt 36 Monate.
Latest News

Search in real time for news and events – topic-specific, live, and contextual to the selected company.

Network

Discover connections between companies via managers, shareholdings, links or addresses here.

Register to see more connections via management and web links. Get access to an interactive network to better understand the environment of this company.

Show more

Products & Technologies

Entwicklung
Biotechnologie
Software
Therapeutika
Anwendungen
Überwachung
Forschung
Produktion
Durchführung von Schulungen
See all 10 entries

Register for a free Implisense account to get advanced analysis and more extensive search results.

Show more

ETHRIS GmbH is mentioned in public sources in the context of the following products and services. Entwicklung, Biotechnologie and Software are the most common. The ranking list shown is without guarantee of completeness or correctness.

Microsoft ProductsMicrosoft Office

The following software solutions, technologies and concepts are often referenced in job postings and press releases of ETHRIS GmbH. Most frequently recognized were Microsoft Office.

Dominance, Competence, ClarityInnovation, Passion, CreativityHarmony, Reliability, CommunicatibilityDilligence, Introspection, Thoroughness

Dominance, Competence, Clarity

Innovation, Passion, Creativity

Harmony, Reliability, Communicatibility

Dilligence, Introspection, Thoroughness

The 4 Color Scheme separates people and their personalities into four groups. ETHRIS GmbH emphasizes the following character types in their external communications and job advertisements.

You can find more information on the FAQ page.

Information for Job Seekers

Based on job advertisements of ETHRIS GmbH, the following specific requirements for job seekers were identified more frequently. Specific requirements can be found in the latest published job advertisements.

Methodische Kompetenz

  • Lernbereitschaft

Persönliche Kompetenz

  • Flexibilität
  • Motivation

The following additional requirements were identified more frequently. These may vary and are provided for guidance.

  • Sprachkenntnisse
Register for free and try Implisense Plus!

Register quickly and easily for a free Implisense account. Registered users have access to extended company profiles and receive more comprehensive search results. If you register with a business email address, we will also set up a free 7-day trial for Implisense Plus in a timely manner.

  • Richer Company Profiles
  • Expanded Search Results
  • Personal Favourites
The company information presented on implisense.com comes from public sources and is verified and aggregated automatically. Implisense cannot guarantee the timeliness, completeness, quality, reliability or accuracy of the data. For questions or suggestions, please use the contact form.

This website uses cookies to provide this service and improve the user experience. Please select the cookies you wish to accept. You can find further information in our data protection declaration.

Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services, we use user statistics such as Google Analytics, which set cookies for user identification. Google Analytics is a service offered by a third party provider.
To improve our services we use proprietary marketing solutions from third parties. These solutions specifically include Google AdWords and Google Optimize, which each set one or more cookies.
Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services, we use user statistics such as Google Analytics, which set cookies for user identification. Google Analytics is a service offered by a third party provider.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.
To improve our services we use proprietary marketing solutions from third parties. These solutions specifically include Google AdWords and Google Optimize, which each set one or more cookies.Some cookies from this site are necessary for the functionality of this service or enhance the user experience. Since these cookies either do not contain any personal data (e.g. language preference) or are very short-lived (e.g. session ID), cookies from this group are mandatory and cannot be deactivated.

Save selectionSelect all